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Dynamics of cellular states of fibro-adipogenic
progenitors during myogenesis and muscular
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Fibro-adipogenic progenitors (FAPs) are currently defined by their anatomical position,
expression of non-specific membrane-associated proteins, and ability to adopt multiple
lineages in vitro. Gene expression analysis at single-cell level reveals that FAPs undergo
dynamic transitions through a spectrum of cell states that can be identified by differential
expression levels of Tie2 and Vcam1. Different patterns of Vcam1-negative Tie2high or Tie2low
and Tie2low/Vcam1-expressing FAPs are detected during neonatal myogenesis, response to
acute injury and Duchenne Muscular Dystrophy (DMD). RNA sequencing analysis identified
cell state-specific transcriptional profiles that predict functional interactions with satellite and
inflammatory cells. In particular, Vcam1-expressing FAPs, which exhibit a pro-fibrotic
expression profile, are transiently activated by acute injury in concomitance with the
inflammatory response. Aberrant persistence of Vcam1-expressing FAPs is detected in DMD
muscles or upon macrophage depletion, and is associated with muscle fibrosis, thereby
revealing how disruption of inflammation-regulated FAPs dynamics leads to a pathogenic
outcome.
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While skeletal muscle stem cells (also referred to assatellite cells—SCs1) are unanimously recognized asthe direct cellular effectors of muscle regeneration2,3,
other cell types are emerging as critical regulators of SCs4–8.
These cells include components of the inflammatory infiltrate
(e.g., macrophages, eosinophils, and neutrophils)9,10 and other
resident cell types, such as mesenchymal cells endowed with a
variable degree of multipotency within the mesoderm-derived
lineages4,11–15. Among them, muscle interstitial fibro-adipogenic
progenitors (FAPs) have been proposed to convert environmental
perturbations into cues that coordinate SC activity upon acute
injury16, indicating that these cells provide a highly dynamic
functional niche for SCs. Indeed, reciprocal and functional
interplay between SC niche components regulates proper execu-
tion of essential events during muscle regeneration, such as SC
transition from quiescence to activation and eventually differ-
entiation into myofibers. Recent studies have revealed the
importance of the timely appearance and clearance of FAPs, in
order to restrict their activity within a specific timeframe during
the regeneration process17. An abnormal persistence of FAPs has
been observed in pathological conditions of chronic muscle
damage (i.e., muscular dystrophies) associated with persistent
inflammation, formation of fibrotic scars, fat deposition, and
impaired muscle regeneration18. Because of their intrinsic ability
to differentiate into fibrotic cells and adipocytes4,11, FAPs are
considered as potential effectors of these maladaptive processes15.
Moreover, FAPs can also adopt alternative lineages, such as the
osteogenic phenotype in response to BMP that appears to mediate
muscle heterotopic ossification19,20. Overall, FAP's ability to
adopt multiple lineages and perform different activities is indi-
cative of their phenotypic and functional heterogeneity in
response to environmental signals. Thus, the identification of
discrete subpopulations of FAPs and their relative contribution to
muscle growth and regeneration in response to physiological or
pathological signals is an urgent issue in regenerative medicine.
Here we report the identification of FAP subpopulations, based
on Tie2 and Vcam1 expression, that reflect a continuum of cell
states in dynamic transition during post-natal myogenesis, muscle
repair and disease—the mdx mouse model of Duchenne Mus-
cular Dystrophy (DMD).
Results
FAP heterogeneity identified by single cell analysis. To address
the FAP heterogeneity, we have performed gene expression
profiling of FAPs at the single cell level using the Fluidigm 96.96
Dynamic Arrays qPCR platform. We compared the profile of
FAPs of young (3 months old) wild-type mice, either unperturbed
(WT) or at 3 days post notexin-mediated intramuscular injury
(WT-inj 3d), the time point at which a substantial increase in
FAPs was reported4,17. FAPs from 3-month-old dystrophic mice
(MDX), the murine model of DMD, provide an experimental
setting for chronic muscle injury (Fig. 1a). FAPs were isolated by
fluorescence-activated cell sorting (FACS) from hindlimb muscles
based on expression of established cell surface markers, as
negative for Ter119, CD45, CD31, and α7 integrin and positive
for CD34 and Sca-14,5,19-21 (Fig. 1a). A total of 87 genes selected
for the analysis (Supplementary Table 1) were previously shown
to be functionally relevant in FAP biology or have been associated
with muscle-derived mesenchymal cells that might phenotypically
or functionally overlap with FAPs4,5,11,13,15–19,22–25.
Principal component analysis (PCA) of the FAP single cell
gene expression data revealed a tendency toward clustering
among cells from the same experimental condition (Fig. 1b and
Supplementary Fig. 1a). Interestingly, PC2 (principal component
2) could distinguish FAPs derived from regenerating muscles
within the context of either acute (WT-inj 3d) or chronic (MDX)
injury from FAPs isolated from unperturbed muscles (WT)
(Fig. 1b). PC1 appears, instead, to discriminate FAPs from acute
and chronic injury (Fig. 1b). We sought to resolve FAP
heterogeneity by clustering and plotting the single cell gene
expression data using the self-organizing maps (SOM) algorithm.
The topological maps (Fig. 1c) are illustrating the average
expression level of each gene for each node of the map. The nodes
represent clusters of single FAPs with highly similar gene
expression profiles, with the number of cells in each node
visualized in Supplementary Fig. 1b. The SOM analysis revealed a
distinct set of genes correlated within the same cell and showing
the highest loadings in PC2 (Fig. 1c, d and Supplementary
Fig. 1a), marking putative subpopulations of FAPs. For example,
Vcam1 expression shows a pattern similar to Runx2, Lbh,
Adam12, Hgf, Lox, Timp1, Pdgfa, Acta2, and Notch3, while high
Tek gene expression is associated with cells that express elevated
levels of Wnt11, Igfbp5, Myoc, Wnt10b, Smpd3, Bmp6, and Bmp7
genes (Fig. 1c). SOM for all the genes in the analysis are shown in
Supplementary Fig. 1c. Co-expression associations among genes
within each cell were independently confirmed by a correlation
matrix (Fig. 1d). Importantly, the gene expression correlation
analysis revealed associations between genes implicated in
common signalling pathways within a single cell. Thus, while
Vcam1 expression preferentially correlated with a pro-fibrotic
gene signature (i.e., Acta2, Pdgfa, Adam12, Lox, Timp1)15,22,24,
high Tek expression preferentially associated with components of
the Wnt and Bmp signalling pathways (Wnt5a, Wnt11, Bmp4,
and Bmp6) (Fig. 1d). Moreover, we observed that in the SOM
analysis, there are nodes containing cells from all experimental
conditions, as well as nodes that instead contain only cells from
one experimental condition (Supplementary Fig. 1d). Noticeably,
the cells clustering in the nodes characterized by a high Vcam1
expression are mostly FAPs isolated from chronic and acute
injury environment (MDX and WT-inj 3d), while the cells in the
SOM nodes associated with high Tek expression are predomi-
nantly WT FAPs isolated from unperturbed muscles (compare
Fig. 1c and Supplementary Fig. 1d). We therefore hypothesized
that such association of single cell gene expression profiles reflects
the existence of discrete FAP subpopulations. Since Vcam1 and
Tek (which encodes for the Angiopoietin receptor, Tie2) are cell
surface markers, we sought to exploit them for prospective
isolation of FAP subpopulations by FACS.
We first simulated the partitioning of FAPs into four
predicted subpopulations (subFAPs) defined by the combined
levels of Vcam1 and Tek expression on single cell level, using a
threshold of 7 log2Ex for both markers (Fig. 1e). The resulting
subgroups are Vcam1high/Teklow (Vcam1+), Tekhigh/Vcam1low
(Tek+), Vcam1high/Tekhigh (double positive, DP), or Vcam1-
low/Teklow (double negative, DN) (Fig. 1e). By visualizing the
experimental conditions on the Tek/Vcam1 gene expression
scatterplot (Supplementary Fig. 1e) and by plotting the
predicted FAPs subpopulations on the PCA (Fig. 1f), we
demonstrate a presumptive association of Tek and Vcam1
expression in FAPs with the different experimental conditions
used in this study. Specifically, we observed that FAPs from the
two conditions characterized by active muscle regeneration,
that is notexin-injured WT mice and MDX mice at early,
regenerative stages of disease, were enriched in Vcam1+
subFAPs. Thus, Vcam1 expression appears to mark a putative
injury-activated subpopulation associated with regenerating
muscles. The Tek+ subpopulation, instead, appears mostly
represented in unperturbed muscles of WT mice. The DN
putative subpopulation was largely represented in all condi-
tions, while double positive (DP) cells were negligible in our
experimental conditions.
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Vcam1 and Tie2 define distinct subFAPs. We next sought to use
FACS to isolate subFAPs, as predicted by the single cell gene
expression analysis, by using antibodies against cell surface
markers Tie2 (encoded by Tek gene) and Vcam1 (Supplementary
Fig. 2a–c). FACS profiles of isolated subFAPs (Fig. 2a) revealed
dynamic patterns of distribution consistent with our single cell
gene expression data (compare Fig. 2b to Fig. 1g). As we isolated
subFAPs based on the relative levels of Tie2 protein (encoded by
Tek) within a continuum of expression profile, and based on the
presence or absence of Vcam1, we will refer to Vcam1-negative
cells as Tie2high or Tie2low subFAPs. By contrast, Vcam1
expressing subFAPs, which are also expressing low levels of Tie2,
will be referred to as Vcam1+ subFAPs. Both Tie2high and
Tie2low subFAPs were present, albeit in different proportions, in
all conditions tested: unperturbed muscles (WT), regenerating
muscles (WT-inj d3) and chronically injured dystrophic muscles
(MDX) (Fig. 2a–c). On the other hand, Vcam1+ subFAPs
appeared exclusively in the context of injury, either acute (WT-inj
d3) or chronic (MDX), and were nearly absent in unperturbed
muscles (WT) (Fig. 2a–c). Thus, the FACS profile of FAPs
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resembled the pattern of subFAP distribution predicted by single
cell gene expression profiling of FAPs (compare Figs. 1g and 2b),
with subFAPs formerly named as DN in the single cell gene
expression analysis, now being renamed as Tie2low, to indicate
that they represent cells within a low range of Tie2 expression.
We noted that the proportionally higher abundance of Tie2high
cells in unperturbed (WT) muscles, as compared to the other
conditions, was only observed in percentage over the whole
population (Figs. 1g, 2b), but not in absolute amount (Fig. 2c). In
this case, given the great disparity in number of cells in the total
Fig. 1 Heterogeneous FAPs population consists of distinct subpopulations of cells. a Experimental workflow for single cell gene expression analysis.
Hindlimb muscles of C57Bl/10 mice were isolated, minced, and enzymatically digested. FAPs were isolated by FACS and loaded on the C1 System
(Fluidigm) to extract RNA, reverse transcribe RNA to cDNA and pre-amplify cDNA from each single cell. Real-time qPCR analysis of single cell-derived
cDNA was performed on the Biomark platform (Fluidigm) for 87 genes. b Principal component analysis (PCA) of single cell gene expression values of FAPs
isolated from WT, WT notexin-injured day 3 (WT-inj d3) and dystrophic MDX mice. c Self organizing maps (SOM) representation of gene expression in
clusters of single FAP cells. Each circle is a cluster of single cells and the fill color represents the level of expression for each gene shown. The expression
scale is shown on the left for each gene individually. Expression is measured as Log2Ex (Log2Ex= Ct(LOD)-Ct(gene)) with LOD= 24 (limit of detection) and
Ct= cycle threshold. d Correlation matrix of single cell gene expression across all cells. Orange color marks high positive correlation, green color marks
high negative correlation. Groups of genes outlined in blue are positively correlated, while the genes outlined in green are negatively correlated.
e Expression scatterplot of Tek and Vcam1 gene expression. Cutoff is set at 7 Log2Ex for both genes based on the SOM graph (c). Tek and Vcam1
expression levels define the predicted subpopulations, marked as Tek(Tie2)+/Vcam− (Tek+) in dark blue, Vcam1+/Tek(Tie2)− (Vcam1+) in brown,
double positive (DP) in light blue and double negative (DN) in gold. f The same PCA as in Fig. 1a but with cells color coded based on the FAPs
subpopulations predicted in Fig. 1e. g Distribution of subpopulations in each experimental condition (n= 2)
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Fig. 2 Vcam1+ and Tie2-expressing cells are dynamic subpopulations of FAPs. a Representative FACS plots of FAPs isolated from hindlimb muscles and
analyzed based on Tie2 and Vcam1 expression in wild type (WT), WT notexin-injured day 3 (WT-inj d3) and dystrophic mdx C57Bl/10 mice (MDX).
b Distribution of subpopulations in each experimental condition by FACS analysis (mean+ s.e.m., n= 4, *p-value P < 0.05; **P < 0.01, ***P < 0.001, ****P <
0.0001). Statistical significance was determined by one-way ANOVA with Bonferroni post hoc test, and comparisons to the WT control group are reported.
c Number of cells in each FAPs subpopulation for each experimental condition by FACS analysis (n= 4, mean+ s.e.m., one-way ANOVA, *P < 0.05, **P <
0.01, ***P < 0.001). d Representative FACS plots of FAPs based on the expression of cell surface markers Tie2 and Vcam1 following notexin (NTX) injury in
WT mice at indicated time points. FAPs were isolated from tibialis anterior (TA) muscles of C57Bl/6J mice. e Quantification of cell numbers for the
subpopulations of FAPs in TA muscles during the time course in d (n= 3 representing independent experiments, mean+ s.e.m.)
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FAPs population between injured and unperturbed muscles, we
were not able to accurately estimate the respective proportion of
the Tie2high subFAPs among the samples.
qPCR analysis confirmed that Vcam1+ and Tie2high subFAPs
isolated from muscles of WT-inj 3d and MDX mice displayed
distinct patterns of gene expression that were consistent with
those predicted by the single cell analysis. Importantly, the
univocal marker of FAPs Pdgfra11, showed comparable expres-
sion levels in all subFAPs (Supplementary Fig. 2d).
To understand the dynamic changes among the identified
subFAPs during the course of skeletal muscle regeneration, we
have monitored the distribution profile of subFAPs by FACS at
different time points following an acute injury by notexin
intramuscular injection (days 1, 2, 3, 4, 5 and 10 post injury),
and compared it to subFAPs isolated from unperturbed muscles.
An immediate, but transient, expansion of Tie2low and Tie2high
subFAPs was detected upon acute injury, with a peak observed at
day 1 post injury. However, while Tie2high promptly returned to
basal levels by day 2, a slower and progressive return to basal
levels was observed with Tie2low subFAPs (Fig. 2d, e and Table 1).
Interestingly, the emergence of Vcam1+ subFAP was observed at
later time points, with a peak between days 2 and 3 post injury
and a gradual return to basal levels between days 5 and 10 post
injury (Fig. 2d, e and Table 1). Overall, the profiles of subFAPs at
day 10 post injury were comparable to those observed in
unperturbed muscles (Fig. 2d, e). This evidence indicates that
transient and temporally coordinated expansion of distinct
subFAPs coincides with muscle repair progression following an
acute injury. It also suggests that the clearance of expanded
subFAPs upon completion of the regeneration process is an
important event for muscle homeostasis. Notably, the observed
dynamics of subFAP appearance was not strain specific, as the
results obtained with C57BL/10 (Fig. 2a) and C57BL/6J (Fig. 2d)
mouse strain could be replicated with mice from ICR/HaJ strain
(Supplementary Fig. 2e–h).
subFAPs exhibit dynamic transcriptional profiles. To further
address subFAP identity and functional relevance, we profiled the
gene expression of each subFAP in different experimental con-
ditions by transcriptome analysis. We performed RNA sequen-
cing (RNA-seq) analysis of bulk FAPs and subFAPs (Tie2high,
Tie2low, and Vcam1+ only, since the DP subFAPs are extremely
rare and therefore not suitable for RNA-seq with the same pro-
tocol) by collecting RNA immediately after isolation from hin-
dlimb muscles of WT mice either unperturbed or at 2 time points
after acute injury—day 1 and day 3 post injury (WT-inj d1 and
WT-inj d3)—as well as from muscles of 3-month-old mdx mice
(MDX). RNA-seq gene expression data (normalized counts)
showed a high correlation with single cell qPCR gene expression
levels (Log2Ex) for all genes marking specific subFAPs (Fig. 1c
and Supplementary Fig. 3a). FAPs markers (Pdgfra, Ly6a/Sca-1)
were highly expressed in all subFAPs in both analyses (Supple-
mentary Fig. 3a). Transcriptomic data of subFAPs revealed dis-
tinctive transcriptional signatures that discriminated individual
subFAPs from each other as well as from the bulk FAPs. The PCA
of subFAPs RNA-seq data showed that the samples cluster by
discrete subpopulations (Fig. 3a), indicating that the subFAPs
identified in this study have distinctive transcriptional profiles
regardless the experimental condition they originated from. The
gene expression profiles of Tie2low and bulk FAPs tend to partly
overlap, consistent with the fact that Tie2low subFAPs account for
the majority of the bulk FAPs in most of the conditions.
In order to identify subFAP-specific gene signatures that could
assign unique identities to individual subFAPs, we first compared
the gene expression profiles of subFAPs vs. bulk FAPs irrespective
of the experimental conditions they originated from (Fig. 3b and
Supplementary Fig. 3b). We found distinctive transcriptional
profiles for each subFAP as well as substantial changes of gene
expression within each subFAP, depending on the experimental
conditions they were isolated from (Fig. 3b). Differential gene
expression (DE) analysis showed that a large number of
differentially expressed genes discriminated Tie2high and Vcam1+
from bulk FAPs, while Tie2low subFAPs displayed minimal
differences in gene expression, when compared to bulk FAPs
(Supplementary Fig. 3b), as it was anticipated by PCA (Fig. 3a).
Functional analysis by gene ontology (GO) revealed subFAP-
specific gene expression profiles predictive of specialized biological
functions (Fig. 3c). For instance, while Vcam1+ subFAPs exhibited
global gene expression signatures predictive of high proliferative
activity and low adhesion properties, Tie2high subFAPs have profiles
predictive of low proliferative activity, but increased propensity to
form focal adhesions (Fig. 3d). Tie2low subFAPs displayed specific
gene expression profiles indicative of chemotactic activity (Fig. 3d).
We next compared subFAP gene expression profiles across
different experimental conditions. To this purpose, we identified
differentially expressed genes in each subpopulation and experi-
mental condition compared to the bulk WT (Supplementary
Fig. 3c). We then compared the enriched biological functions in
all the conditions with Ingenuity Pathway Analysis (IPA)
(Fig. 3e–g). This analysis revealed a dynamic regulation of
subFAPs during the transition from unperturbed muscles to
progressive stages of regeneration following acute injury, or in
pathological conditions, such as chronic degeneration/regenera-
tion of mdx muscles (Fig. 3e). Remarkable dynamics was
observed during the transition from day 1 to 3 post injury, when
both Tie2high and Tie2low subFAPs appeared to acquire
transcriptional properties predictive of specific biological func-
tions, such as chemotaxis of blood cells, and of canonical
pathways, such as dendritic cell maturation (Fig. 3f, g). This
evidence suggests that subFAPs that displayed similar temporal
kinetics (Fig. 2d–f) can also share some biological functions
presumably related to coordination of inflammation-related
events during early regeneration stages. Within this context, we
also observed that by day 3 post injury Tie2low, and, to a certain
extent, Tie2high subFAPs displayed changes in gene expression
that reflect their ability to promote neo-angiogenesis (Fig. 3f). The
presence of both Tie2high and Tie2low subFAPs in unperturbed
muscles and the large overlap in their gene expression profiles
(Supplementary Fig. 3b) suggest that they likely represent a
continuum of cellular states in dynamic transition, upon
sequential exposure to a plethora of cues generated within the
regenerative environment along with the process of muscle repair.
Accordingly, during the regeneration process unique transcrip-
tional signatures could discriminate Tie2high and Tie2low
subFAPs, such as Tie2high-specific expression of genes implicated
in muscle growth, or Tie2low-specific expression of genes
implicated in cell spreading (Fig. 3f). Another distinctive
Table 1 Time course analysis: number of cells per subFAPs
during muscle regeneration (related Fig. 2e)
Vcam1+ Tie2high Tie2low
WT 67 547 4065
WT-inj 1d 14,969 10,133 74,283
WT-inj 2d 41,009 2690 25,803
WT-inj 3d 21,945 559 11,072
WT-inj 4d 3301 592 9768
WT-inj 5d 2453 980 7947
WT-inj 10d 230 175 3365
Average cell number per population is indicated (n= 3)
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biological function between Tie2high and Tie2low subFAPs was the
enrichment in the apoptosis signalling observed in Tie2high as
well as in Vcam1+ subFAPs at day 3 post injury (Fig. 3g). Cell
proliferation (as reflected by an enrichment in the expression of
genes implicated in DNA metabolism) was instead the dominant
biological process invariably identified in Vcam1+ subFAPs in all
the experimental conditions (Fig. 3f).
Overall, the reported changes in the transcriptional profiles of
subFAPs along the progression of the regeneration process
suggest that individual subFAPs could perform specific tasks
within discrete temporal windows, presumably through reciprocal
interactions with other cellular components of the regenerative
environment. Among these interactive networks, the temporal
control of subFAP activity appears of particular interest. Previous
works indicated that timely clearance of FAPs by macrophages is
required to restrict their activity within a specific window of time
during muscle repair in response of acute injury17. In this regard,
it is interesting to note the opposite pattern of subFAP-mediated
control of dendritic cell maturation between day 1 and day 3,
which likely reflects a FAPs-dependent regulation of macrophage
phenotypic switch that has been implicated in the termination of
the regeneration-associated inflammatory activity and the
clearance of FAPs10,26,27. Interestingly, the subFAP-mediated
dendritic cell maturation was not observed in mdx muscles
(Fig. 3f, g), consistent with a defective regulation of macrophages
previously observed in dystrophic muscles17. Likewise, compar-
ison of subFAP gene expression profiles between regeneration
post-acute injury and mdx muscles exposed to a chronic damage/
regeneration cycles revealed a number of biological processes that
were dysregulated in subFAPs isolated from mdx muscles (Fig. 3f,
g). For instance, the gene expression profiles that accounted for
the ability of subFAPs to promote muscle growth (Tie2high
subFAPs), neo-angiogenesis (Tie2low subFAPs), and chemotaxis
(both Tie2high and Tie2low subFAPs) were lost in mdx muscles
(Fig. 3f). Likewise, a global reduction of the apoptosis signaling
was observed in FAPs isolated from mdx mice, as compared to
acutely injured WT mice (Fig. 3g).
Unsupervised clustering of RNA-seq profiles separated bulk
FAPs and all subFAPs from other muscle-derived cell types, such
as SC and macrophages (Supplementary Fig. 3d). Interestingly,
tissue-resident fibroblasts, such as cardiac muscle, dermal, lung,
and synovial fibroblasts, appeared to cluster separately from
subFAPs, suggesting that pro-fibrogenic Vcam1+ subFAPs are
distinct from tissue-resident fibroblasts.
Fibrosis is the most deleterious pathological event during
the progression of DMD and other chronic disorders28–32. As
Vcam1+ subFAPs were detected in mdx muscles, and because
Vcam1+ subFAP single cell expression profile showed an
association with pro-fibrotic genes (Fig. 1c, d), we interrogated
the RNA-seq data set for specific enrichment in pro-fibrotic genes
in Vcam1+ and other subFAPs. To this purpose, we assembled a
list of genes that have been previously implicated in the regulation
of fibrosis and myofibroblast identity22,24,31–35 and determined
their relative expression in the subFAPs. An elevated expression
of pro-fibrotic genes such as Acta2, Lox, Adam12, Timp1, Col1a1,
and Col3a1 was observed in Vcam1+ subFAPs, as also predicted
by the single cell gene expression analysis (Fig. 1c and
Supplementary Figs. 1c and 4a). Other genes implicated in
activation of fibrosis, such as Snai1, Mmp13, Mmp9, Serpinh1,
Stat1, and Itgb1 were also enriched in Vcam1+ subFAPs
(Supplementary Fig. 4a). The heatmap also illustrated specific
dynamics of expression of fibrosis-associated genes in Vcam1+
subFAPs along with the regeneration stages post-injury. For
instance, some genes were abundantly expressed at day 1 post
injury, but their expression declined at day 3 post injury (i.e.,
Plau, Nfkb1, Tgif1, Myc, Cebpb, Serpine1, Smad7, Smad2, Mmp3,
Itgb8, Cav1, and Eng). Of note, most of these genes were also
expressed at day 1 post injury in Tie2low subFAPs, which was
indeed the subpopulation that more closely clustered with
Vcam1+ subFAPs (Supplementary Fig. 4a). By contrast, other
fibrosis-associated genes were not expressed in Vcam1+ subFAPs
at day 1 post injury, but showed a robust expression at day 3 post
injury (i.e., Stat1, Lox, Serpinh1, Acta2, Itbg1, Mmp9, Foxm1, and
Snai1). Moreover, few genes were already expressed in Vcam1+
subFAPs, but not in Tie2low subFAPs, and were upregulated in
Vcam1+ subFAPs at day 3 post injury (i.e., Snail1, Mmp13).
Interestingly, while the large majority of fibrosis-associated
genes expressed in Vcam1+ and Tie2low subFAPs at day 1 post
injury were not expressed in Vcam1+ subFAPs isolated from
mdx muscles, most of the genes upregulated in Vcam1+ subFAPs
at day 3 post injury were also expressed in Vcam1+ subFAPs
from mdx muscles (Supplementary Fig. 4a). These gene
expression dynamics suggests a progressive acquisition of a pro-
fibrotic phenotype by Vcam1+ subFAPs during the regeneration
process in response to acute injury, with a retention of late-stage
(day 3 post injury) “transcriptional signatures” observed in
Vcam1+ subFAPs of dystrophic muscles. The intermediate
expression levels of some pro-fibrotic genes at day 3 post injury,
as well as the detection of few day 1 post injury pro-fibrotic genes
in Vcam1+ subFAPs from mdx muscles, are likely accounted for
by the presence of asynchronously activated FAPs at different
stages of transition through a continuum of cell states, that might
reflect the response to repeated cycles of degeneration-
regeneration process typically observed in DMD muscles. More-
over, markers of fibrotic deposition in the extracellular matrix
(ECM), such as Col1a1 and Col1a2, as well as Tgfb1 and Tgfb3,
were preferentially expressed in Vcam1+ (and moderately in
Tie2low) subFAPs only from mdx muscles. On the other hand, the
lack of expression in Vcam1+ subFAPs from mdx muscles of
certain genes that were expressed in Vcam1+ subFAPs
from regenerating muscles post-acute injury (i.e., IL13ra2, Timp1,
and Lox) suggests that disease-specific transcriptional profiles
can discriminate dystrophic Vcam1+ subFAPs from the
regeneration-activated counterpart.
Of note, this analysis also revealed clusters of genes
mainly involved in inflammation, but only indirectly implicated
in fibrosis (Ccr2, Ccl3, Il1b, Jun, Cxcr4, and Tnf) that were
selectively expressed in Tie2low and Tie2high subFAPs at day 3
post injury. Likewise, another cluster of genes preferentially
expressed in Tie2high subFAPs was enriched in genes
implicated in the BMP signaling, as also anticipated by the single
cell analysis (Fig. 1c) and previous works19,25. Among these
genes, we noticed the expression of a well-known inhibitor of
fibrosis, Bmp736, which might explain the low pro-fibrotic profile
of these cells.
Collectively, RNA-seq analysis of subFAPs predicts specific
biological functions during regeneration in response to acute
injury and reveals pathological gene expression signatures of
subFAPs in dystrophic muscles.
Distinct subFAPs associate with neonatal and adult myogenesis.
Among the functional interactions predicted by the RNA-seq
analysis (Fig. 3), the interplay between subFAPs and the
inflammatory infiltrate was emerging as a nodal exchange of
regulatory signals that determines whether muscles are repaired
by SC-mediated regeneration or by fibrotic deposition.
To further investigate the relationship between subFAPs,
inflammatory response, SC-mediated myofiber formation, and
fibrosis, we compared the subFAPs activation profile during
muscle regeneration either in the presence or absence of
inflammatory infiltrate. We have monitored subFAPs profiles
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following an acute muscle injury, a condition in which SC
activation is associated with the presence of an inflammatory
infiltrate, as well as during neonatal muscle growth, in which SC
activation is uncoupled from an inflammatory response. We
observed a robust activation of Tie2-expressing subFAPs during
neonatal myogenesis at days 8–10 after birth, while no activation
of Vcam1+ subFAPs was observed, in striking contrast with the
Vcam1+ expansion during regeneration post-acute injury
(Fig. 4a, b, Supplementary Fig. 4b, see also Fig. 2). This evidence
points to inflammatory infiltrate as a major determinant of
Vcam1+ subFAP activation.
Previous studies have shown how the inflammatory infiltrate
regulates the muscle regeneration process at multiple levels27,37,
including macrophage-mediated clearance of FAPs during the
resolution of the regeneration process in order to prevent
fibrosis17. Defective clearance of FAPs by macrophages has been
reported in dystrophic muscles, in association with a chronic
inflammation and fibrosis15. We used a mouse model of
macrophage depletion, the ITGAM-DTR/EGFP (hereafter
referred to as ITGAM-DTR) mice, to further investigate the
regulatory role of macrophage on Vcam1+ subFAPs clearance. In
this mouse model the diphtheria toxin receptor (DTR) and green
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Fig. 4 SubFAPs are distinctly associated with neonatal and injury-induced myogenesis. a Representative FACS plots of FAPs analyzed based on Tie2 and
Vcam1 expression in adult wild type (WT), adult WT notexin-injured day 3 (WT-inj d3) and neonatal WT C57Bl/6J mice (postnatal day 8–10). FAPs were
isolated from hindlimb muscles. b Distribution of subpopulations in each experimental condition by FACS analysis (mean+ s.e.m., n= 6 (three
independent experiments, each including biological duplicates), *P < 0.05, ****P < 0.0001). Statistical significance was determined by one-way ANOVA
with Bonferroni post hoc test, and comparisons to the WT control group are reported. c Experimental design of the macrophage depletion study. ITGAM-
DTR mice were used for this study. Acute muscle injury (Inj) was induced with either NTX (10 µl of 10 µg/ml notexin) or CTX (10 μl of 10 μM cardiotoxin).
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d7) and 7 days after an acute injury in the context of macrophage depletion (ITGAM-inj d7+ 2xDT). Quantification of fibrosis in muscle sections stained
with Sirius Red (e-right panel; n= 4, mean+ s.d., t-test, **P < 0.01). Scale bar 200 µm. f Representative FACS plots profiles of Vcam1+ cells within FAPs
population. g Percentage of Vcam1+ FAPs in the conditions analyzed in f. Statistical significance was determined by one-way ANOVA with Bonferroni post
hoc test, and only comparisons to the control ITGAM (*) and to ITGAM-Inj. 7d (#) groups are reported (mean+ s.d., n= 3 independent experiments,
ANOVA, ***P < 0.001, ##P < 0.01)
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fluorescent protein (EGFP) are expressed under the control of the
human ITGAM (integrin alpha M) promoter (CD11b), and
macrophage depletion can be induced by intraperitoneal (ip)
injection of diphtheria toxin (DT)27,37. As the macrophage
population tends to be restored by day 4 post-DT administra-
tion27, sequential DT injections every 3 days led to a persistent
perturbation of macrophage dynamics, consisting of a reduction
of macrophages (Fig. 4c and Supplementary Fig. 4c, d), with a
residual population detected that is likely accounted for by
resumption of early pro-inflammatory (M1) macrophages25. This
led to an altered clearance of cell infiltration, persistence of
necrosis and formation of fibrotic lesions that were detected in
muscles at 7 days post injury (Fig. 4d, e). The impact of
macrophage depletion on Vcam1+ subFAPs clearance from
muscles following acute injury was then evaluated by FACS-
mediated cell isolation from muscles of ITGAM-DTR mice
exposed to injury followed by sequential injections of DT or
control (PBS). DT-mediated alteration of macrophage dynamics
resulted in the aberrant retention of Vcam1+ subFAPs in muscles
at day 7 post injury (Fig. 4f, g and Supplementary Fig. 4e). This
evidence further emphasizes the functional relationship between
the inflammatory infiltrate, the regulation of Vcam1+ subFAP
and the formation of fibrotic scars during chronic, pathological
regeneration (i.e., DMD).
Finally, we evaluated whether the dynamics of subFAPs
typically observed in unperturbed conditions was skewed toward
an enrichment in Vcam1+ subFAPs in diaphragm of mdx mice
at early stages of disease progression (6 weeks old mice),
compared to age-matched control (WT) mice. The diaphragm
is an involuntary muscle subjected to continuous contraction
cycles that permit breathing. As such, it is invariably used from
birth and is therefore the earliest muscle to develop fibrosis
during DMD progression, showing the most pronounced
accumulation of fibrotic areas15. Diaphragms of 6-week-old-WT
mice exhibited a higher ratio between Tie2high and Tie2low
subFAPs, compared to the limb muscles used for the previous
analysis, presumably because of more intense contractile activity
and younger age (compare Supplementary Fig. 4f-g with Fig. 2d).
Remarkably, mdx diaphragms exhibited a significant reduction in
percentage of Tie2high subFAPs and a proportional increase in
Vcam1+ subFAPs (Supplementary Fig. 4f, g).
Discussion
Single cell gene expression profiling of FAPs revealed that the
relative expression levels of two cell surface markers, Tie2 and
Vcam1, can be exploited for the prospective isolation by FACS of
three subpopulations of FAPs that exhibit distinct dynamics of
appearance in muscles upon specific environmental cues (neo-
natal muscle growth, adult homeostasis, and regeneration by
acute or chronic injury).
While Tie2-expressing subFAPs (either Tie2low or Tie2high)
account for the vast majority of resident FAPs in unperturbed
muscles, Vcam1 expression marks an injury-activated sub-
population that was functionally associated with the presence of
an inflammatory infiltrate. We found that the relative levels of
Tie2 expression resolve Tie2-expressing FAPs into two sub-
populations, Tie2low and Tie2high subFAPs that show distinct
dynamic profiles during muscle regeneration following acute
injury or during neonatal muscle growth. The overlap in the gene
expression profiles of all subFAPs (including common FAP sur-
face markers, such as Sca1, Pdgfrα, and CD90)4,11,21,38 together
with the emergence of transcriptional signatures that discriminate
the various subFAPs upon muscle perturbation suggest that
subFAPs range through a spectrum of cell states that are in
dynamic transition. SubFAPs are regulated by signals that also
trigger SC expansion and differentiation into myofibers, either
within the neonatal muscle growth or during adult life (i.e.,
muscle repair in response to acute injury). This is consistent with
previous studies from Goldhamer lab that identified Tie2+ pro-
genitor cells also expressing the FAP markers Pdgfrα and Sca-1
and displaying an adipogenic potential19,25. It is therefore likely
that during development the bulk of FAPs consists of Tie2-
expressing cells, and an initial bifurcation from this lineage could
be provided by an expansion of Tie2high subFAPs observed in
concomitance with SC amplification and muscle growth during
neonatal life. While the upregulation of Tie2 (coding for the
Angiopoietin receptor) suggests that enhanced response to
Angiopoietin might contribute to this process, future studies are
required to determine the molecular regulation of Tie2low-to-
Tie2high transition.
The appearance of Vcam1+ subFAPs in adult life coincides
with muscle perturbations associated with an inflammatory
response, e.g., regeneration of injured myofibers. Thus, two dis-
tinct types of FAP activation can occur during SC expansion and
formation of new muscles, in response to different stimuli; while
neonatal myogenesis appears dominated by a selective activation
of Tie2high subFAPs, during adult life injury-activated muscle
regeneration triggers a more complex response that includes
sequential and partially overlapping waves of macrophages, as
well as other inflammatory cells, and a spectrum of FAP func-
tional states that include both Tie2high and Vcam1+ subFAPs.
The different abundance and kinetic of appearance of Tie2high
and Vcam1+ subFAPs, together with the dynamic gene expression
profiles revealed by RNA-seq analysis of subFAPs, suggest that
they represent distinct cellular states of a functional continuum
within a broader cell population (bulk FAPs) that enables muscles
to adapt to the diversity of demands imposed by various types of
muscle perturbations. In particular, the emergence of Vcam1+
subFAPs during adult life, in association with the inflammatory
response to muscle injury, indicates a transition toward a pro-
fibrotic state consistent with the requirement of a transient
deposition of extracellular matrix to promote asymmetric division
of SC within a defined temporal window, a mechanism that enables
adult skeletal muscles to regenerate in response to repeated inju-
ries39,40. Of note, this process is compromised in SC from DMD
muscles, because of deregulation of intrinsic and/or extrinsic
properties6,41. We propose that Vcam1+ subFAPs accumulation in
DMD muscles and the ensuing formation of fibrotic scars, possibly
caused by pathological behavior of macrophages, can also con-
tribute to impair SC activity at late stages of disease.
The association of Vcam1+ subFAPs with inflammation and
fibrosis, and their pro-fibrotic gene expression profile, suggest
that they are candidate cells for the origin of myofibroblasts—the
direct effectors of fibrosis42. However, we note that Vcam1+
subFAP can be discriminated from resident fibroblasts by their
ability to undergo adipogenesis in vitro, upon culture with adi-
pogenic medium, a unique biological property that currently
defines FAPs. Our experience with culturing of subFAPs ex vivo
isolated from their physiological context indicates that subFAPs
rapidly lose their identity and are extremely unstable. While the
instability of subFAPs in vitro is consistent with their dynamic
transition from one state to another in response to regulatory
signals, it should also warn against potential biases in the inter-
pretation of data generated from prolonged ex vivo cultures of
FAPs, where signals from serum growth factors replace the reg-
ulatory cues in vivo. While these caveats have complicated so far
the identification of specialized subpopulations, our analysis of
the transcriptional profile of FAPs immediately after their isola-
tion have revealed the existence of subFAPs that represent a
spectrum of cellular states highly responsive to environmental
cues, such as inflammation. Indeed, our data sets from the single
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cell gene expression analysis and RNA-seq of subFAPs provide
criteria for a molecular definition of subFAPs in dynamic tran-
sition that would not be otherwise captured by current standard
assays, such as adipogenic differentiation.
This study discloses a previously unappreciated complexity of
FAP biology by revealing their dynamic specialization into sub-
FAPs in physiological and disease conditions, and provides the
foundation for future strategies targeting specific subFAP in order
to further determine their role in vivo.
Methods
Animals and in vivo procedures. All protocols were approved by the Sanford
Burnham Prebys Medical Discovery Institute (SBP) Animal Care and Use Com-
mittee (IACUC) and the Italian Ministry of Health, National Institute of Health
(IIS) and Santa Lucia Foundation (Rome). Mice were age, sex, and strain matched.
Normal wild-type (wt) C57Bl/10 and mdx (C57Bl/10 and C57Bl/6J) mice were
purchased from the Jackson laboratory. C57Bl/6J and ICR/HaJ mice colonies were
maintained in SBP vivarium. Acute injury and muscle regeneration were induced
in 2–3-month-old wt C57/BL10 or C57/BL6J by intramuscular injection of 10 µl of
10 μg/ml notexin (NTX, Sigma) into the tibialis anterior (TA), gastrocnemius or
quadriceps. Alternative acute muscle injury was performed by intramuscular
injection of 10 µl of 10 µM cardiotoxin (CTX, Sigma) into TA muscles. Mice were
killed post injury at the time points indicated in figures. For postnatal myogenesis
studies, hindlimb muscles from 8 to 10 days old pups were utilized. For experi-
ments using diaphragms, 6-week-old normal wt C57Bl/6J and mdx C57Bl/6J mice
were used.
ITGAM-DTR mice were obtained from the Jackson Laboratory. Tibialis
anterior (TA) and gastrocnemius (GA) muscles of young (8–12 weeks) ITGAM-
DTR mice were injured by intramuscular (IM) injection of notexin (NTX) or
cardiotoxin (CTX), as described above. The administration of the diphtheria toxin
(DT) (Sigma) was done by intraperitoneal (ip) injection of 200 µl of DT solution
(12 ng/per gram of body weight; diluted in PBS) prior to muscle injury (3–4 h
before NTX or CTX administration). As monocyte/macrophage population is
restored by day 4 following a single intraperitoneal dose of DT, mice were subjected
to a second injection of DT at day 3 after injury. DT- and vehicle-treated mice were
killed at 7 days post injury and hindlimb muscles were collected for cell isolation
and histological assessment of muscle regeneration and fibrosis progression.
FACS-mediated isolation of FAPs and Macrophages. FAPs for single cell ana-
lysis were isolated from diaphragm and hindlimb skeletal muscles (as indicated on
the figures) by fluorescence-activated cell sorting (FACS), as previously described20.
Briefly, hindlimb muscles were mechanically minced and enzymatically digested in
FACS buffer (HBSS (Gibco) containing 0.4 mM CaCl2 and 5 mM MgCl2, 0.2% (w/
v) bovine serum albumin (BSA) (IgG-free, protease-free, Jackson ImmunoR-
esearch)) containing 2 mg/ml (0.45 U/ml) Collagenase A (Roche) and 2.4 U/ml
Dispase I (Roche) for 45–50 min at 37 °C in a rotating water bath. Cell suspension
was diluted with FACS buffer and filtered through 70 µm nylon cell strainer (BD
Falcon). Cells were immune-labeled with primary antibodies anti-CD31-
PacificBlue (RM5228, Life Technologies, 4 µg/ml), anti-CD45-eFluor450 (clone 30-
F11, eBioscience, 4 µg/ml), anti-Ter119-eFluor450 (clone TER-119, eBioscience,
4v µg/ml), anti-Sca-1-FITC (clone E13-161.7, BD Pharmingen, 10 µg/ml), CD34-
Alexa Fluor 647 (clone RAM34, BD Pharmingen, 10 µg/ml) and anti-α7 integrin-
PE (clone R2F2, AbLab, 2 µg/ml) for 30 min at 4 °C, in a FACS buffer. Cells were
washed and resuspended in FACS Buffer and filtered through 40 µm strain filter.
FxCycleTM Violet Stain (Life Technologies) was used to label dead cells. Flow
cytometry analysis and cell sorting were performed on a FACSAria instrument, and
the data were analysed by FACSDiva 6.1.3 software and by FlowJo. Live FAPs were
isolated as Ter119-/CD45-/CD31-/α7-integrin-/ CD34+/Sca-1+ cells.
FAPs subpopulations were isolated from diaphragm and hindlimb muscles as
described above and sorted by FACS after immune labeling as follows, using the
primary antibodies anti-CD31-PacificBlue (RM5228, Life Technologies, 2 µg/ml),
anti-CD45-eFluor450 (clone 30-F11, eBioscience, 4 µg/ml), anti-Ter119-eFluor450
(clone TER-119, eBioscience, 4 µg/ml), anti-Sca-1-FITC (clone E13-161.7, BD
Pharmingen, 10 µg/ml), anti-α7 integrin- Alexa Fluor 647 (clone R2F2, AbLab,
4 µg/ml), anti-Tie2-PE (clone TEK4, BioLegend, 8 µg/ml), and anti-Vcam1-PE•Cy7
(clone 429 MVCAM.A, BioLegend, 1 µg/ml) for 45 min at 4 °C, in a FACS Buffer
containing 10% goat serum. After the immune-staining cells were processed for
FACS analysis as described above. FMO controls were prepared with aliquots of
cells. Single color controls were prepared using UltraComp eBeads (eBioscience).
Flow Cytometry studies were performed at the Sanford Burnham Prebys
Medical Discovery Institute Flow Cytometry Core using LSRFortessa X-20 cell
analyzer and FACSAria sorter (BD), and the data were analysed by FACSDiva
6.1.3 software.
For macrophage isolation, hindlimb skeletal muscles were processed as
described above and analyzed by FACS in LSRFortessa X-20, but also in DAKO-
Cytomation MoFlo High Speed Sorter, analysing data by Summit V4.3 software
(Beckman Coulter). The staining- protocol is identical and the following antibodies
were used: anti-CD45-eFluor450 (clone 30-F11, eBioscience), anti-CD11b-PE-Cy7
(clone M1/70, eBioscience, 1:200), anti-F4/80-PE (clone BM8, eBioscience, 1:50),
and anti-GR1-e780 (clone RB6-8C5, eBioscience, 1:200).
All FACS data were further analysed by FlowJo version 10.0.4 (FlowJo LLC).
Single cell capture and cDNA preparation. C1 Single-Cell Auto Prep System
(Fluidigm) was used for isolation of FAPs single cell RNA (isolated from
male mice), following the manufacturer’s protocol (#100-4904, Fluidigm), using
10–17 µm medium size C1 IFC. Integrity of captured FAPs on the C1 IFC was
determined under the confocal microscope. Captured cells were lysed and the RNA
was reverse transcription and cDNA was pre-amplified using DELTAgene Assays
targeting 87 selected genes (Supplementary Table 1).
BioMark real-time PCR on single cell cDNA. Collected pre-amplified cDNA was
analysed by real-time PCR using Fast Gene Expression Analysis protocol with
EvaGreen® on the BioMark HD System with 87 selected gene-specific assays
(Supplementary Table 1) (protocol #68000088, Fluidigm), skipping the exonuclease
I treatment of C1 collected cDNA20.
Single cell gene expression data analysis. Data analysis after BioMark qPCR is
described in detail in our Methods and Protocols chapter20. Briefly, we manually
checked for data quality in the BioMark RT-PCR analysis software and we
extracted the data. Data manipulation was performed in R, where we first elimi-
nated all the data marked as “Fail” in the CtCall.
During the quality control of single cell gene expression data analysis, genes that
failed qPCR reactions and cells that either did not express FAP identification
markers (Sca1 and Pdgfra) or expressed SC markers (Itga7) or endothelial marker
(Pecam1/CD31) were excluded from the data set in order to avoid the inclusion of
cell types different from FAPs in the analysis. We then calculated the gene
expression level as Log2Ex (Log2Ex= Ct(LOD)-Ct(gene)) and set low expressing cells
(Log2Ex < 0) to zero. We used a LOD of 24, as estimated by Livak et al.43. All
graphs were produced in R. SOM analysis was performed with kohonen package in
R (v2.0.19).
RNA isolation and qPCR analysis. RNA from FAPs was extracted using miR-
Neasy Micro kit (Qiagen) following the manufacturer’s protocol, including DNase
treatment of the samples. cDNA was synthetized using QuantiTect Reverse
Transcription kit (Qiagen) and analysed by real-time quantitative PCR (RT-PCR)
using SYBR Green PCR Master Mix (Applied Biosystems), using primers provided
in Supplementary Table 2. Relative expression was calculated using 2−Δct
method44, Gapdh housekeeping gene expression was used to normalize gene
expression.
RNA sequencing. SubFAPs and FAPs were isolated from hindlimb muscles of
C57Bl/10 male mice in two independent experiments. The number of cells ranged
between 7700 and 230,000. RNA from FAPs was extracted using miRNeasy Micro
kit (Qiagen) following the manufacturer’s protocol. RNA was shipped to the
sequencing facility as dry pellet in RNAstable® (Biomatrica). The libraries for
sequencing were prepared using Ovation SoLo RNA-Seq System by NuGEN.
For each experimental condition two independent experiments were carried out
for the isolation of RNA. All biological duplicates are from different cohorts of
mice, sorted at different times.
RNA sequencing data processing. For sequencing alignment, we used the human
reference genome assembly GRCm38/mm10 (http://ftp.ensembl.org/pub/release-
76/fasta/mus_musculus/dna/), while for transcriptome annotation we used the
version 85 of the GRCm38 (http://ftp.ensembl.org/pub/release-85/gtf/
mus_musculus/Mus_musculus.GRCm38.85.gtf.gz).
We used the FASTQC package (v0.11.3) to assess the quality of sequenced
libraries. All passed quality control.
Because, we were using the Ovation SoLo RNA-Seq System by NuGEN, we
adhered to the manual suggestions and trimmed 5 bases from the 5′ of the
sequences.
Reads were mapped to the reference genome using TopHat2 v.2.1.145. We used
the following non-default TopHat2 parameters: -p 48 -g 1 --library-type fr-
firststrand. The number of mapped reads ranged between 23 and 44 × 106 and the
percentage of mapping was between 79 and 92%.
The quality control of the reads distribution along transcripts was performed
using infer-experiment.py from RSeQC package v2.6.346. All samples had a
uniform distribution of reads along transcripts.
The sequenced read counts per annotated gene were derived with the use of
htseq-count script distributed with HTSeq v0.5.4p547. We used the R library
package DESeq2 v.1.12.448 for measuring differential gene expression between two
different cell conditions, considering the two RNA-Seq experiments as biological
replicates. We picked genes with adjusted p-value < 0.01.
Gene ontology analysis was performed using Ingenuity pathway analysis (IPA;
http://www.1ingenuity.com). All graphs were produced in R.
Public RNA-seq data from mouse tissue-resident fibroblasts were downloaded
from GEO with accession numbers GSM1223640 and GSM1223641 (cardiac
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fibroblasts), GSM521651 (lung fibroblasts), GSM2500874, GSM2500875 and
GSM2500876 (synovial fibroblasts), and GSM2067698, GSM2067699 and
GSM2067700 (skin fibroblasts) (see Supplementary Table 3). Data sets from
Satellite cells (SRR7075694, SRR7075695, SRR7075698, SRR7075699, SRR7075710,
SRR7075711), and macrophages (SRR7075704, SRR7075705, SRR7075706,
SRR7075707, SRR7075708, SRR7075709) were kindly provided by S. Consalvi and
V. Saccone (Iannotti et al., in preparation). Data were aligned on mm10 version of
UCSC mouse genome with Tophat2 and quantified with htseq-count. Counts data
from all conditions were filtered based on their raw count, keeping only those
where the sum of the counts for all samples is higher than 1, then normalized and
logged with DESeq2 v.1.4.5 rlog function, and samples were clustered according to
the 50% most variable genes with hclust function, using Pearson correlation
coefficient as distance and complete as linkage, respectively, in R-3.1.0.
Histological and immunofluorescence analyses. Muscle cryosections were fixed
in 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA) and stained with
Haematoxylin/Eosin solution (Sigma-Aldrich), according to standard procedure.
Fibrosis was measured using Sirius Red staining protocol. Briefly, muscle
cryosections were fixed in bouin solution 1 h at 56 °C. Sections were stained in
Picro-Sirius red solution for 1 h at RT protected from light. After a brief washing in
acidified water, sections were fixed in 100% ethanol and the final dehydration was
performed in xylene 100%. Sections were mounted with EUKITT® and visualized
using a Nikon Eclipse 90i. Fibrotic index was calculated as the percentage of red
positive areas using Image J software. The figures reported are representative of all
the examined fields.
Statistics. Statistical analysis was performed in GraphPad Prism 7 (GraphPad
Software Inc, La Jolla, CA, USA). Comparisons between two groups were tested
using an unpaired t-test. Comparisons between multiple groups were tested using
one-way ANOVA and Bonferroni post hoc tests. Differences were considered
significant at the P < 0.05 level.
Data availability
RNA-seq data supporting the findings of this study have been deposited in the GEO data
repository under the accession code GSE100474. Other data that support the findings of
this study are available under the accession codes GSM1223640, GSM1223641,
GSM521651, GSM2500874, GSM2500875, GSM2500876, GSM2067698, GSM2067699,
GSM2067700, SRR7075694, SRR7075695, SRR7075698, SRR7075699, SRR7075704,
SRR7075705, SRR7075706, SRR7075707, SRR7075708, SRR7075709, SRR7075710,
SRR7075711.
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